---
schema_version: "secwatch.filing_event.v1"
accession: "0001746473-26-000046"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:24:45.416824+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pliant Therapeutics enters $50M at-the-market equity facility with Leerink; terminates prior Cantor agreement

## Summary
- Entered Sales Agreement with Leerink Partners for ATM offering of common stock up to $50 million.
- Terminated 2021 Sales Agreement with Cantor Fitzgerald; no penalties incurred and no shares had been sold under it.
- New ATM program provides continued market-based equity financing flexibility.

## SEC filing metadata
- accession: 0001746473-26-000046
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000174647326000046/0001746473-26-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000174647326000046/plrx-20260327.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001746473-26-000046
- JSON: https://secwatch.observer/filing/0001746473-26-000046.json
- Plain text: https://secwatch.observer/filing/0001746473-26-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.